To Continue the Momentum in Women’s Health, We Have No Time to Lose
We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need.
Search, Click, Enroll? What Clinical Trials Can Learn from E-commerce
Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Five Strategies To Boost Clinical Trial Diversity
Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.
Alleviating Patient Burden in Clinical Trials: Modeling a Consumer-Grade Experience
By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.
Atropos Health, Seqster Team Up to Reduce Disparities in Clinical Trials
Atropos Health and Seqster joined forces to address historical diversity and inclusion challenges in clinical trials. The partnership seeks to enable the swift creation of turnkey patient registries that generate real world evidence from existing registries in under 48 hours.
Health Equity Begins with Increasing Diversity in Clinical Research: AI Can Help
It’s critical that we address these examples of institutionalized bias and racism in how we approach clinical trials for drugs and devices. While it’s a daunting task, the path forward is surprisingly clear, and AI can be instrumental in the next step of overcoming unconscious biases inherent in clinical trial processes.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Inato Snags $20M to Make Clinical Trials More Diverse & Accessible
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they're interested.
How Patient Monitoring Is Poised to Revolutionize Healthcare
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.
Putting Patients First: Seeking To Solve Long-standing Challenges With Clinical Research Participation and Access
Clinical research as a care option is a means of connecting patients with clinical research as part of their ongoing health care, located where they receive that care, and offered by their trusted provider.
Agents of change: How the Gen Z medical science liaison will transform healthcare
Gen Z is the most diverse, digitally-proficient generation yet. Gen Z MSLs have the skills and power to change the future of healthcare by using technology to redefine who KOLs are, how they are engaged, and ultimately, how clinical trials are run – and with it the potential to make health equity a reality.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Key metrics for successful D&I in the drug development lifecycle
Taking steps to eliminate health disparities among people of color and ensuring diversity throughout the development cycle should be a strategic goal for all. Medical Affairs can be the change agents within their organizations to help with this push.
Lack of diversity in clinical trials isn’t just a recruiting problem—it’s a data problem
To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.
Technology considerations to promote inclusion, equity and diversity in clinical research
Underrepresented groups traditionally were thought to have limited access to technology. But internet access is on the rise and researchers can take steps to increase participant diversity and be more inclusive.
Restoring trust in clinical trials among Black communities
Whether seeking to overcome ongoing hesitation of the Covid-19 vaccine or searching for moonshot cancer solutions, whatever the healthcare need demands, seeking results for diverse populations must be a priority.
To make trials more inclusive, H1 wants to help find the right physicians
The company rolled out a tool to help pharmaceutical companies pull together information about clinical trial sites and identify the best physician investigators for a trial.